Business - Briefly   

Drug for diabetic foot ulcers from DRL

HYDERABAD: Dr. Reddy's Laboratories announced the launch of Plermin (generic name: Recombinant Human Platelet Derived Growth Factor — rhPDGF), the first drug to be launched in India for the treatment of diabetic foot ulcers. The product would be available as a gel in 7.5 gm and 15 gm tubes.

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts: Classifieds | Employment | Updates: Breaking News |

Stories in this Section

Scheme to replace DEPB on anvil
Motorola to invest $17 m in India R&D centre
`Exempt perishables from VAT'
EU in a quandary over Chinese textiles
Rupee gains further
Tata Steel recommissions blast furnace
Areva to buy Alstom's T&D business in India
@Road expands activities
Nortel invests $10 m in Sasken
Tata Tea's exit worries planters
Taj Business Hotels to expand
Tata Motors breaks new ground
Sensex drops 61 points on late selling
Bullion rates
Exchange rates
Nod for Reliance investment
TUI, Le Passage sign JV
Samsung's new investment
New president for Honda Siel
Drug for diabetic foot ulcers from DRL
Redington to sell Xerox products
RINL expects 20 p.c. rise in net
RBI cancels registration of NBFC
Inforte, Cognizant to offer CRM solutions
New chief scientific officer for Matrix
CCL records Rs. 900 crore profit
HP launches range of consumer notebooks
Award for Moser Baer CMD

Copyright © 2005, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu